Adrenergic beta-blocking agents.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents; D001007:Anxiety / Q000188:drug therapy; D002312:Cardiomyopathy, Hypertrophic / Q000188:drug therapy; D006321:Heart / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007545:Isoproterenol / Q000037:antagonists & inhibitors; D008566:Membranes / Q000187:drug effects; D008881:Migraine Disorders / Q000188:drug therapy; D011950:Receptors, Cholinergic / Q000187:drug effects; D011968:Receptors, Histamine / Q000187:drug effects; D012083:Renin / Q000097:blood; D012559:Schizophrenia / Q000188:drug therapy; D013329:Structure-Activity Relationship; D013566:Sympathomimetics; D013610:Tachycardia / Q000188:drug therapy; D014202:Tremor / Q000188:drug therapy
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D011950:Receptors, Cholinergic; D011968:Receptors, Histamine; D013566:Sympathomimetics; D012083:Renin; D007545:Isoproterenol